Clinical course of a Japanese girl with Leber congenital amaurosis associated with a novel nonsense pathogenic variant in : a case report and mini review.

Tomoyasu Kayazawa, Kazuki Kuniyoshi, Yoshikazu Hatsukawa, Kaoru Fujinami, Kazutoshi Yoshitake, Kazushige Tsunoda, Hiroshi Shimojo, Takeshi Iwata, Shunji Kusaka

Journal: Ophthalmic genetics 2022;43(3):400-408

PMID: 35026968

Abstract

Leber congenital amaurosis (LCA), although rare, is one of the most severe forms of early-onset inherited retinal dystrophy (IRD). Here, we review the molecular genetics and phenotypic characteristics of patients with associated IRD. The longitudinal clinical and molecular findings of a Japanese girl diagnosed with LCA associated with pathogenic variants in c.648delG, (p.Trp216Ter*) and c.709C>T (p.Arg237Cys) have been described to highlight the salient clinical features of -associated IRD.

Address: Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka, Japan.; Department of Ophthalmology, Osaka Women's and Children's Hospital, Osaka, Japan.; Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.; Genetics, UCL Institute of Ophthalmology Associated with Moorfields Eye Hospital, London, UK.; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.; Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.; Graduate School of Agricultural and Life Science, Faculty of Agriculture, The University of Tokyo, Tokyo, Japan.; Department of Ophthalmology, Graduate School of Medicine, Osaka University, Osaka, Japan.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.